V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002615 | 210006127 | null | 114.5 | null | 2019-12-22 | 2019-12-25 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101606428 |
| 210002617 | 210006129 | 1.56 | 55.4 | Adjuvant (A) | null | 2019-12-13 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100001877 |
| 210002619 | 210006131 | 1.77 | 52 | Palliative (P) | 2018-11-19 | 2018-11-21 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | PACLITAXEL | 100723465 |
| 210002620 | 210006132 | 1.64 | null | Adjuvant (A) | null | 2016-08-22 | PACLITAXEL | 02 | N | PACLITAXEL | 100961564 |
| 210002621 | 210006133 | 1.5 | 160 | Adjuvant (A) | 2018-09-28 | 2018-12-08 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100980853 |
| 210002622 | 210006134 | 1.43 | 58.1 | Adjuvant (A) | 2019-09-01 | 2019-09-03 | Trastuzumab | 02 | N | TRASTUZUMAB | 101714029 |
| 210002623 | 210006135 | 1.6 | 75.6 | Adjuvant (A) | 2016-12-07 | 2016-12-21 | Paclitaxel 7 day | null | N | PACLITAXEL | 101029144 |
| 210002624 | 210006136 | 1.6 | null | Adjuvant (A) | 2017-12-13 | 2018-01-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100432041 |
| 210002625 | 210006137 | 1.61 | 43 | Palliative (P) | 2019-02-18 | 2019-02-25 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100085288 |
| 210002627 | 210006138 | 1.6 | 63.4 | Palliative (P) | null | 2019-04-30 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101539902 |
| 210002628 | 210006139 | 1.45 | 61 | Palliative (P) | 2018-02-26 | 2018-05-07 | Trastuzumab | 02 | null | TRASTUZUMAB | 101416903 |
| 210002629 | 210006140 | null | 67.4 | null | 2016-08-21 | 2016-09-05 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100485064 |
| 210002632 | 210006143 | 1.43 | 87.3 | Adjuvant (A) | 2016-05-23 | 2016-10-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100208875 |
| 210002633 | 210006144 | 1.54 | 49 | Adjuvant (A) | 2016-08-26 | 2017-01-18 | Docetaxel | 02 | N | DOCETAXEL | 100957328 |
| 210002636 | 210006147 | 1.54 | 62.7 | Adjuvant (A) | 2019-07-03 | 2019-09-16 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100183183 |
| 210002637 | 210006148 | 1.64 | 75.9 | Adjuvant (A) | null | 2019-12-24 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101493616 |
| 210002638 | 210006149 | 1.71 | 70.7 | 03 | 2019-04-22 | 2019-05-07 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101227941 |
| 210002639 | 210006150 | 1.6 | 60.6 | Adjuvant (A) | 2017-02-01 | 2017-02-08 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101227330 |
| 210002641 | 210006152 | 1.59 | 71.5 | Neo-adjuvant (N) | 2019-12-29 | 2020-01-13 | PACLITAXEL | 02 | N | PACLITAXEL | 100385496 |
| 210002643 | 210006154 | 1.6 | 79.8 | Neo-adjuvant (N) | 2016-07-29 | 2016-07-29 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100274856 |
| 210002644 | 210006155 | 1.65 | null | Adjuvant (A) | null | 2018-09-08 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101704040 |
| 210002645 | 210006156 | null | 86.5 | null | 2017-12-23 | 2018-01-05 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101572667 |
| 210002648 | 210006157 | null | 94 | null | 2018-05-16 | 2018-08-02 | TRASTUZUMAB | null | null | TRASTUZUMAB | 101843835 |
| 210002649 | 210006158 | 1.64 | 74.3 | null | 2018-01-13 | 2018-01-30 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100533627 |
| 210002650 | 210006159 | 1.56 | 68.6 | null | 2016-09-13 | 2016-11-30 | Docetaxel | 02 | null | DOCETAXEL | 100570355 |
| 210002651 | 210006160 | 1.63 | 114 | null | 2018-05-04 | 2018-11-01 | PACLITAXEL | null | N | PACLITAXEL | 100764006 |
| 210002653 | 210006162 | 1.63 | 104.25 | Palliative (P) | 2018-04-04 | 2018-04-26 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100093279 |
| 210002657 | 210006164 | 1.58 | null | Adjuvant (A) | 2019-05-19 | 2019-10-31 | PACLITAXEL | N | N | PACLITAXEL | 101287575 |
| 210002660 | 210006166 | 1.67 | 53.2 | Neo-adjuvant (N) | null | 2018-10-02 | TRASTUZUMAB EMTANSINE | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101045872 |
| 210002661 | 210006167 | 1.62 | 63.2 | Curative (C) | 2017-10-13 | 2017-10-27 | Carboplatin + Docetaxel | null | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101653172 |
| 210002662 | 210006168 | 1.55 | 0 | null | 2018-08-25 | 2018-09-07 | FEC 100 | N | null | FEC | 101694590 |
| 210002663 | 210006169 | null | 53 | null | 2018-05-02 | 2018-05-23 | Cyclophosphamide + Docetaxel | N | null | CAPECITABINE | 100836789 |
| 210002665 | 210006170 | 1.67 | null | Palliative (P) | 2019-03-18 | 2019-04-08 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | null | N | LETROZOLE + PALBOCICLIB | 101673584 |
| 210002668 | 210006171 | null | null | null | 2016-04-09 | 2016-04-10 | null | null | null | PERTUZUMAB | 100207652 |
| 210002670 | 210006173 | null | 53.2 | null | 2018-07-06 | 2018-07-28 | null | null | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100535601 |
| 210002671 | 210006174 | null | null | null | 2019-10-12 | 2019-10-20 | Trastuzumab(Kadcyla®) (Maintenance) | N | null | CARBOPLATIN | 100432042 |
| 210002672 | 210006175 | null | null | null | 2018-05-17 | 2018-05-24 | FEC 100 | null | null | FEC | 101420735 |
| 210002674 | 210006176 | null | null | null | 2018-02-07 | 2018-04-19 | null | 02 | null | LETROZOLE + PALBOCICLIB | 101657779 |
| 210002675 | 210006177 | 1.7 | 0 | null | 2016-06-27 | 2016-06-30 | FEC + DOCETAXEL | null | null | FEC + DOCETAXEL | 101286413 |
| 210002677 | 210006179 | 1.67 | 66.6 | Palliative (P) | null | 2017-08-03 | EC | 02 | null | EC | 100072849 |
| 210002679 | 210006181 | null | 80 | null | 2020-01-02 | 2020-01-18 | FEC + DOCETAXEL | N | null | FEC + DOCETAXEL | 101145468 |
| 210002684 | 210006183 | 1.67 | 64.2 | Palliative (P) | 2019-03-15 | 2019-03-30 | Paclitaxel+Trastuzumab wkly Maint | 02 | N | PACLITAXEL + TRASTUZUMAB | 100660215 |
| 210002686 | 210006185 | 1.64 | 61.1 | null | null | 2019-07-01 | FEC 100 | null | null | FEC | 101344582 |
| 210002690 | 210006188 | 1.62 | 72.7 | Adjuvant (A) | 2018-07-28 | 2018-11-24 | Trial Unspecified | null | N | EC | 101000028 |
| 210002695 | 210006192 | 1.66 | 77.5 | null | 2020-04-18 | 2020-05-07 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100147319 |
| 210002696 | 210006193 | null | 0 | null | 2019-01-22 | 2019-01-29 | FEC 100 | N | null | FEC | 100348719 |
| 210002697 | 210006194 | null | null | null | 2017-10-25 | 2017-11-08 | FEC + DOCETAXEL | 01 | null | FEC + DOCETAXEL | 101293716 |
| 210002698 | 210006195 | 1.5 | 59.9 | Neo-adjuvant (N) | 2020-09-24 | 2020-09-24 | FEC + DOCETAXEL | null | N | FEC + DOCETAXEL | 100824686 |
| 210002699 | 210006196 | 1.65 | null | Adjuvant (A) | 2016-08-30 | 2016-08-31 | EC | null | N | EC | 100907431 |
| 210002701 | 210006198 | null | 52 | null | 2018-03-07 | 2018-09-10 | Trastuzumab(Kadcyla®) (Maintenance) | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100082008 |